发明名称 Bitsüklilised heteroaromaatsed ühendid kui valgu türosiini kinaasi inhibiitorid
摘要 Compounds of formula (I) and salts or solvates thereof are disclosed <CHEM> wherein Y is CR<1> and V is N; or Y is CR<1> and V is CR<2>; R<1> represents CH3SO2CH2CH2NHCH2-Ar-, wherein Ar is furan or thiazole, each of which may optionally be substituted by one or two halo, C1-4 alkyl or C1-4 alkoxy groups; R<2> is hydrogen C1-4 alkoxy or halo; R<3> is benzyl, halo-, dihalo- or trihalobenzyl, benzoyl, pyridylmethyl, pyridylmethoxy, phenoxy, benzyloxy, halo-, dihalo- or trihalobenzyloxy or benzenesulphonyl; R<4> is halo or C1-4 alkoxy or is not present; and wherein either (a) R<3> represents 3-fluorobenzyloxy; and/or (b) R<4> is halo and is substituted in the 3-position of the phenyl ring; and wherein halo represents fluoro, chloro or bromo. <??>Processes for the preparation of the compounds, pharmaceutical formulations of the compounds, the use of the compounds in therapy, and methods of treatment of inter alia cancer and malignant tumours by administration of the compounds is also disclosed.
申请公布号 EE200000411(A) 申请公布日期 2001.12.17
申请号 EE20000000411 申请日期 1999.01.08
申请人 GLAXO GROUP LIMITED 发明人 MALCOLM CLIVE CARTER;GEORGE STUART COCKERILL;STEPHEN BARRY GUNTRIP;KAREN ELIZABETH LACKEY;KATHRYN JANE SMITH
分类号 A61K31/47;A61K31/4709;A61K31/505;A61K31/517;A61K31/519;A61P9/10;A61P17/06;A61P29/00;A61P35/00;A61P43/00;C07D221/00;C07D239/00;C07D239/94;C07D405/04;C07D405/14;C07D417/04;C07D417/14;C07D471/04 主分类号 A61K31/47
代理机构 代理人
主权项
地址
您可能感兴趣的专利